Annual CFI
-$148.41 M
-$147.80 M-24150.33%
31 December 2023
Summary:
Enliven Therapeutics annual cash flow from investing activities is currently -$148.41 million, with the most recent change of -$147.80 million (-24150.33%) on 31 December 2023. During the last 3 years, it has fallen by -$147.95 million (-32093.49%). ELVN annual CFI is now -77602.62% below its all-time high of -$191.00 thousand, reached on 31 December 2021.ELVN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$14.83 M
+$48.49 M+144.04%
30 September 2024
Summary:
Enliven Therapeutics quarterly cash flow from investing activities is currently $14.83 million, with the most recent change of +$48.49 million (+144.04%) on 30 September 2024. Over the past year, it has increased by +$50.38 million (+141.71%). ELVN quarterly CFI is now -61.68% below its all-time high of $38.69 million, reached on 31 December 2023.ELVN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$1.96 M
+$50.38 M+104.05%
30 September 2024
Summary:
Enliven Therapeutics TTM cash flow from investing activities is currently $1.96 million, with the most recent change of +$50.38 million (+104.05%) on 30 September 2024. Over the past year, it has increased by +$189.16 million (+101.05%). ELVN TTM CFI is now at all-time high.ELVN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELVN Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10000.0% | +141.7% | +101.0% |
| 3 y3 years | -10000.0% | - | - |
| 5 y5 years | - | - | - |
ELVN Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | <-9999.0% | at low | -61.7% | +109.8% | at high | +101.0% |
| 5 y | 5 years | <-9999.0% | at low | -61.7% | +109.8% | at high | +101.0% |
| alltime | all time | <-9999.0% | at low | -61.7% | +109.8% | at high | +101.0% |
Enliven Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $14.83 M(-144.0%) | $1.96 M(-104.1%) |
| June 2024 | - | -$33.66 M(+88.2%) | -$48.41 M(-70.9%) |
| Mar 2024 | - | -$17.89 M(-146.2%) | -$166.27 M(+12.0%) |
| Dec 2023 | -$148.41 M | $38.69 M(-208.8%) | -$148.41 M(-20.7%) |
| Sept 2023 | - | -$35.55 M(-76.5%) | -$187.20 M(+23.4%) |
| June 2023 | - | -$151.52 M(>+9900.0%) | -$151.66 M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$31.00 K(-69.3%) | -$449.00 K(-26.6%) |
| Dec 2022 | -$612.00 K(+220.4%) | -$101.00 K(+621.4%) | -$612.00 K(+19.8%) |
| Sept 2022 | - | -$14.00 K(-95.4%) | -$511.00 K(+2.8%) |
| June 2022 | - | -$303.00 K(+56.2%) | -$497.00 K(+156.2%) |
| Mar 2022 | - | -$194.00 K | -$194.00 K |
| Dec 2021 | -$191.00 K(-58.6%) | - | - |
| Dec 2020 | -$461.00 K | - | - |
FAQ
- What is Enliven Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Enliven Therapeutics?
- What is Enliven Therapeutics annual CFI year-on-year change?
- What is Enliven Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly CFI year-on-year change?
- What is Enliven Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Enliven Therapeutics?
- What is Enliven Therapeutics TTM CFI year-on-year change?
What is Enliven Therapeutics annual cash flow from investing activities?
The current annual CFI of ELVN is -$148.41 M
What is the all time high annual CFI for Enliven Therapeutics?
Enliven Therapeutics all-time high annual cash flow from investing activities is -$191.00 K
What is Enliven Therapeutics annual CFI year-on-year change?
Over the past year, ELVN annual cash flow from investing activities has changed by -$147.80 M (-24150.33%)
What is Enliven Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ELVN is $14.83 M
What is the all time high quarterly CFI for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly cash flow from investing activities is $38.69 M
What is Enliven Therapeutics quarterly CFI year-on-year change?
Over the past year, ELVN quarterly cash flow from investing activities has changed by +$50.38 M (+141.71%)
What is Enliven Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ELVN is $1.96 M
What is the all time high TTM CFI for Enliven Therapeutics?
Enliven Therapeutics all-time high TTM cash flow from investing activities is $1.96 M
What is Enliven Therapeutics TTM CFI year-on-year change?
Over the past year, ELVN TTM cash flow from investing activities has changed by +$189.16 M (+101.05%)